MedTrace Logo

The NORwegian Atrial Fibrillation Self-SCREENing

NCT05914883 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50000

Last updated 2025-07-29

No results posted yet for this study

Summary

Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.

Conditions

Interventions

DIAGNOSTIC_TEST

Long-term continuous ECG monitoring

Long-term continuous ECG monitoring with ECG247 Smart Heart Sensor

Sponsors & Collaborators

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Haukeland University Hospital

    collaborator OTHER

  • St. Olavs Hospital

    collaborator OTHER

  • University Hospital of North Norway

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Sigrun Halvorsen, PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05914883 on ClinicalTrials.gov